A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
CHOC, University Lab Partners establish unique training program for the next generation of biotech innovators
A joint effort from CHOC and ULP is aimed at inspiring Orange County high school students to become the next generation of biotech innovators.
CHOC study shows reduced risk of emergency department COVID-19 infection
Asymptomatic healthcare workers in a community with a low COVID-19 prevalence who undergo daily screenings are unlikely to be carriers.
How QR codes could improve cast care for pediatric patients
Quick response codes could supplement physicians’ instructions for at-home cast care and further reassure patients and families.
DBT in IOP setting shown to reduce intensity, frequency of suicidal thoughts in teens
CHOC’s intensive outpatient program for high school teens is successfully intervening on suicidal behaviors.
